SABCS 2023 | Risk stratification in invasive lobular carcinoma: iLobular Prognostic Tool

Jason Aboudi Mouabbi, MD, University of Texas MD Anderson Cancer Center, Houston, TX, explains the rationale behind the iLobular Prognostic Tool which is the first tool developed for the risk stratification of patients with invasive lobular carcinoma (ILC). Historically, patients with ILC have been grouped with patients with the more common invasive ductal carcinoma (IDC). However, with the use of this new tool, patients with ILC can be evaluated more specifically to meet their needs, maximizing the chances of a successful outcome overall. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.